We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGI icon
8651
Birks Group
BGI
$6.82M
$16K ﹤0.01%
+16,324
New +$19.6K
CARM
8652
CALL
DELISTED
Carisma Therapeutics
CARM
$16K ﹤0.01%
560
-1,395
-71% -$44.5K
EGY icon
8653
Vaalco Energy
EGY
$608M
$16K ﹤0.01%
+11,025
New +$21.1K
HOV icon
8654
PUT
Hovnanian Enterprises
HOV
$787M
$16K ﹤0.01%
948
+328
+53% +$10.4K
PULM icon
8655
Pulmatrix
PULM
$5.7M
$16K ﹤0.01%
328
-46
-12% -$3.39K
TGB
8656
PUT
Trekor Metals
TGB
$3.06B
$16K ﹤0.01%
34,700
-4,400
-11% -$2.83K
ATYR
8657
aTyr Pharma
ATYR
$56.4M
$16K ﹤0.01%
+2,248
New +$18.8K
LUMO
8658
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$16K ﹤0.01%
1,133
-3,589
-76% -$63.2K
NBSE
8659
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$16K ﹤0.01%
478
+433
+962% +$31.4K
TBLT
8660
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
0
IMBI
8661
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$16K ﹤0.01%
+4,047
New +$36.9K
NYMX
8662
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$16K ﹤0.01%
11,900
-17,800
-60% -$32.6K
MBII
8663
DELISTED
Marrone Bio Innovations, Inc.
MBII
$16K ﹤0.01%
10,803
-17,096
-61% -$26.2K
LEJU
8664
CALL
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$16K ﹤0.01%
+1,110
New +$17.6K
JASN
8665
DELISTED
Jason Industries, Inc.
JASN
$16K ﹤0.01%
+11,929
New +$27.2K
QTRH
8666
DELISTED
Quarterhill Inc. Common Shares
QTRH
$16K ﹤0.01%
16,020
-2,565
-14% -$2.93K
SKYS
8667
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$16K ﹤0.01%
12,368
+2,464
+25% +$3.63K
CYTR
8668
DELISTED
CytRx Corp
CYTR
$16K ﹤0.01%
34,569
+4,477
+15% +$3.09K
MTL.PR
8669
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$16K ﹤0.01%
+25,153
New +$19K
DGSE
8670
DELISTED
DGSE Companies, Inc.
DGSE
$16K ﹤0.01%
35,238
+3,848
+12% +$2K
AEHR icon
8671
Aehr Test Systems
AEHR
$4.32B
$15K ﹤0.01%
10,727
-3,340
-24% -$6.24K
BWEN icon
8672
Broadwind
BWEN
$124M
$15K ﹤0.01%
+11,892
New +$21.2K
ESEA icon
8673
Euroseas
ESEA
$512M
$15K ﹤0.01%
+3,314
New +$26.7K
FSI icon
8674
Flexible Solutions
FSI
$64M
$15K ﹤0.01%
+10,742
New +$15.6K
TGB
8675
CALL
Trekor Metals
TGB
$3.06B
$15K ﹤0.01%
+31,000
New +$19.9K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.